Kirkland, Wash.- Radiant Research Inc., the nation's largest Site Management Organization (SMO), announces the acquisition of the Preventive Cardiology Institute of Minneapolis. The Minneapolis acquisition lengthens Radiant's lead among other SMOs in the areas of lipid and weight loss research.

Background Information
Radiant Research | Minneapolis will be directed by experienced investigator James H. Zavoral, MD. Dr. Zavoral has conducted sponsored clinical trials since 1986 and has served as principal investigator on over 100 studies. His site, The Preventive Cardiology Institute is recognized as one of the nation's leading sites in lipid and weight loss research. Dr. Zavoral has published numerous scientific articles in peer-reviewed publications including the New England Journal of Medicine and the Journal of the American Medical Association and is past president of Minnesota's American Heart Association. "I have dedicated my life to the practice of preventive cardiology and to clinical trials. I believe that the innovative drug development process is enhanced by a national organization of top quality research sites such as Radiant Research. I'm a clinician and a researcher, not a businessman. Joining Radiant allows me to pursue my passion while at the same time knowing that the business end of things is in good hands," stated Dr. Zavoral.

Stated Eric Hayashi, Vice President of Corporate Development: "We feel quite fortunate to have an investigative site of the caliber of the Preventive Cardiology Institute join our family. Having acquired so many of the nation's top sites, we've now become the organization that other top investigative sites want to join, and that sponsors are encouraging sites to join."

                                                             ###

About Radiant Research
Based near Seattle, Washington, Radiant Research (radiantresearch.com) is a comprehensive clinical research and development company serving the biopharmaceutical and medical device industry. Radiant is comprised of more than 30 wholly-owned premier clinical research centers nationwide, employing over 500 clinical research professionals exclusively focused on providing professional, high quality study conduct and drug development services. In the past four years, Radiant has conducted more than 8,000 clinical trials across 18 therapeutic specialties.

Contact:
Michael K. Lester Chief Executive Officer RADIANT RESEARCH (425) 468-6200	Pamela M. Spaniac Chief Financial Officer RADIANT RESEARCH (425) 468-6200